Cancer Research News

cancer diagnosis

The emotional impact of false positive cancer diagnosis

False positives in cancer diagnosis cost NHS millions each year and cause huge anxiety across the nation, Wesley Baker, CEO of ANCON Medical discusses the impact of outdated cancer diagnosis.
urine test, smear test, cervical cancer

Urine test could replace smear test for cervical cancer

University of Manchester scientists latest research finds that urine testing may be as good as the smear test for preventing cervical cancer.
Precision oncology

Towards Precision Oncology in Breast Cancer

Predicting Response to Neoadjuvant Chemotherapy Using Tumor Vasculature Characteristics.
your smear test invitation, cervical cancer

Why you should accept your smear test invitation

Everyone susceptible to cervical cancer should understand how to prevent it. Cervical screening saves 2,000 lives each year, read on to find out how to potentially save your own.
prostate cancer

Prostate cancer: A riddle wrapped in a mystery inside an enigma

Professor Malcolm Mason, Cancer Research UK’s Prostate Cancer Expert reveals why prostate cancer is a riddle wrapped in a mystery inside an enigma
bowel cancer screening

Bowel cancer screening should start at age 50, according to expert committee

The independent expert screening committee has recommended that bowel cancer screening in England should in future start at age 50 to prevent late diagnosis
prostate cancer

Prostate Cancer UK calls for screening programme and more research

Angela Culhane, Prostate Cancer UK Chief Executive discusses the tools needed to create a screening programme to stop prostate cancer killing men.
cancer

We need to think differently about cancer to save more lives

Sir Harpal Kumar, former CEO of Cancer Research UK, outlines his vision for cancer in the future and said that earlier diagnosis would enable the UK to catch up with its international counterparts in terms of survival rates and would also make the NHS more efficient
acute myeloid leukaemia

Living with acute myeloid leukaemia (AML)

Bethany Torr, Campaigns and Advocacy Officer at Leukaemia Care explores the challenges of living with acute myeloid leukaemia (AML)
prostate cancer

Prostate cancer: A wake-up call for men

Roger Wotton, Chairman of Tackle Prostate Cancer explores the key issues around prostate cancer, the most common cancer in men.
molecular signalling

TGF-β signalling – Tumor biology in prostate cancer

Identifying the molecular signalling pathways leading to advanced prostate cancer to improve therapy and diagnosis
cancer diagnosis

New data reveals cancer diagnosis could affect treatment options

Data from Public Health England shows that cancer diagnosis could impact upon which kind of treatment a patient receives.

Prostate cancer: Enigmatic, with different shades

Professor Ghulam Nabi from the University of Dundee explores the subject of the enigmatic prostate cancer, with different shades 
cancer diagnosis

Artificial Intelligence to improve cancer diagnosis

Ambitious new plans set out by the Prime Minister today will see around 22,000 fewer people dying from cancer each year by 2033
Prostate cancer

Prostate cancer treatment receives £75m funding boost

Prime Minister Theresa May has announced a further £75m in funding for “earlier and faster” diagnosis and treatment of prostate cancer, which kills more than 10,000 men each year
troublesome piece of tissue

The prostate gland: A most troublesome piece of tissue

Europa Uomo – European Prostate Cancer Coalition Secretary, John Dowling shares his thoughts on the prostate gland, described as a most troublesome piece of tissue.
triple-negative breast cancer

New research uncovers how cancer stem cells drive triple-negative breast cancer

Researchers have identified a new stem cell pathway that allows triple-negative breast cancer to thrive, with their findings potentially pointing the way towards more effective treatments
chronic lymphocytic leukaemia

Chronic lymphocytic leukaemia (CLL) and acute myeloid leukaemia (AML): Leukaemia patients watching and worrying

Bethany Torr, campaigns and advocacy officer at Leukaemia Care discusses the impact of chronic lymphocytic leukaemia (CLL) and acute myeloid leukaemia (AML) on patients
care in oncology

Need for supportive care in oncology will increase during the next decade

The need for supportive care in oncology will increase as patients continue to live longer and cancer progresses to become more like a chronic...
Acute myeloid leukaemia

Acute myeloid leukaemia (AML) and cytarabine pharmacogenomics

Professor Jatinder Lamba from the Department of Pharmacotherapy and Translational Research gives an in-depth perspective on acute myeloid leukaemia (AML) and cytarabine pharmacogenomics Acute myeloid...

Follow Open Access Government

Latest Special Reports

Latest Health eBooks